Guillaume Pénaranda

4.0k citations
120 papers · 2.7k indexed · h-index 28
  • Hepatology top 0.5%
    • Hepatitis C virus research 52
    • Hepatocellular Carcinoma Treatment and Prognosis 15
    • Liver Disease and Transplantation 10
    • Liver Disease Diagnosis and Treatment 43
    • Hepatitis B Virus Studies 40
    • Cervical Cancer and HPV Research 11
  • Nephrology top 5%
  • Virology top 5%
    • Molecular Biology Techniques and Applications 7
    • Cholangiocarcinoma and Gallbladder Cancer Studies 6

Guillaume Pénaranda

114 papers receiving 2.7k citations

Peers

Guillaume Pénaranda
Comparison fields: 5 of 112
  • Hepatology 1.6k
  • Epidemiology 1.5k
  • Nephrology 187
  • Virology 114
  • Infectious Diseases 298
Replace Paolo Sacchi with:
Paolo Sacchi Italy
Mark Wright United Kingdom
Robert L. Carithers United States
Fabrizio Fabrizi Italy
Joan Genescà Spain
F. Fabrizi Italy
William Sievert Australia
Dominique Roulot France
Doug Dieterich United States
Antonio González Spain
Guillaume Pénaranda relative to Paolo Sacchi Italy Paolo Sacchi's profile →
Citations per field
00.5×1.5×2.4×
Paolo Sacchi · 1×
Citations per year

Countries citing papers authored by Guillaume Pénaranda

Since Specialization
Citations

This map shows the geographic impact of Guillaume Pénaranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Pénaranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Pénaranda more than expected).

Fields of papers citing papers by Guillaume Pénaranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Pénaranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Pénaranda. The network helps show where Guillaume Pénaranda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guillaume Pénaranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guillaume Pénaranda Line = papers co-authored together Guillaume Pénaranda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20250
4 20234
5 20227
6 20219
7 20202
8 20193
9 20188
10 20166
11 201557
12 20153
13 2014117
14 201415
15 201457
16 20102
17 201053
18 200921
19 20081
20 20081

About Guillaume Pénaranda

Guillaume Pénaranda is a scholar working on Hepatology, Epidemiology and Virology, having authored 120 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (52 papers), Liver Disease Diagnosis and Treatment (43 papers), Hepatitis B Virus Studies (40 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cervical Cancer and HPV Research (11 papers), Liver Disease and Transplantation (10 papers), Molecular Biology Techniques and Applications (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Hepatology (1.6k citations), Epidemiology (1.5k citations) and Nephrology (187 citations). Guillaume Pénaranda has collaborated with scholars based in France, United States and Israel. Frequent co-authors include Philippe Halfon, Marc Bourlière, Denis Ouzan, Hacène Khiri, Christophe Renou, P. Cacoub, Albert Tran, Stanislas Rebaudet, Fares Benmiloud and Fabrice Carrat. Their work appears in journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026